Investment in Alzheimer’s 16x lower than oncology despite ‘exploding public health crisis’
Research into Alzheimer’s disease is suffering from a chronic lack of investment, after clinical trial failures across the field, a report by BIO suggests.
Archives for May 29, 2019
GSK’s shingles vaccine approved in China
GSK is investing in ‘significant’ capacity expansion to support production of its shingles vaccine, which has been approved in China after clinical trials demonstrated 90% efficacy.
Cytonus’ tech helps oncolytic viruses evade immune system
Cytonus will present at BIO regarding the development of Cargocytes, which offer a delivery system for immunotherapy treatments.
A ‘truly translational mindset’ requires the correct tool for the correct job: Synlogic
Translational research faces new challenges – and opportunities – with the rapid growth in precision medicine and new drug modalities, as the industry looks to quickly bring new treatments to patients.
Cel-Sci’s arthritis vaccine ‘reprogramming’ the immune system
Cel-Sci’s rheumatoid arthritis treatment, developed under an $1.5m NIH grant, will be featured at the BIO Convention in Philadelphia next week.
Evotec jumps into biologics through $90m Just.Bio acquisition
Evotec to join the emerging biologics market through Just Biotherapeutics’ smart technology platforms, machine learning tools and low cost manufacturing facilities.
Rexgenero extends European reach with expanded manufacturing
Partnership with German Red Cross will see Rexgenero’s lead drug candidate reaching broader patient base in clinical trials.